NRX-0305

N/A

Report date: 2026/04/29 20:02:18

NME

Base Information

Drug NameNRX-0305

Drug Alias NameNRX-0305

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionSerine/threonine-protein kinase B-raf degraders

TargetsSerine/threonine-protein kinase B-raf

Therapy Area/IndicationsUrinary Bladder NeoplasmsMelanomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsUrinary Bladder NeoplasmsMelanoma

Inactive IndicationsNeoplasms

ATC CodeN/A